Skip to content

Advance Care Planning: Promoting Effective and Aligned Communication in the Elderly

Improving Advance Care Planning in Oncology: A Pragmatic, Cluster-Randomized Trial Integrating Patient Videos and Clinician Communication Training

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03609177
Acronym
ACP-PEACE
Enrollment
13800
Registered
2018-08-01
Start date
2020-04-15
Completion date
2024-09-30
Last updated
2025-10-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Other Cancer

Keywords

Cancer Care

Brief summary

In this research study, the investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may improve health care delivery. \- It is expected that about 30,000 people will take part in this research study, 29,550 of these patients, the vast majority, will be included only for medical record review.

Detailed description

The purpose of this study is to improve the quality of care provided to millions of older Americans with cancer. The investigators are working to help oncologists better serve patients by delivering more patient-centered, goal-concordant care that may dramatically improve health care delivery. This is pragmatic stepped wedge cluster randomized trial (SW-CRT) of a Comprehensive ACP (Advance Care Planning) Program among older oncology patients. The ACP Program will include training clinicians in communication skills and using video decision aids for participants. \- This study will involve medical record review of 30,000 people age 65 or older with advanced cancer. We will also recruit 450 eligible patients (150 patients from each of our three sites broken down into 75 patients during the control phase and 75 patients during the intervention phase) to conduct a survey for our secondary patient-centered outcomes (confidence, satisfaction with physician communication, patient decisional satisfaction and regret). From among this sub-group we will engage 240 participants (80 from each of our three sites broken down into 40 patients during the control phase and 40 patients during the intervention phase) in an activity to film video declarations of their preferences. During the first year, three pilot sites (one at each health care system) will trial the intervention. The subjects recruited at these pilot sites will not be included in the final analysis. Thus, the main trial will begin during year 2 and continue through year 5 with recruitment of 30,000 subjects for the primary outcome at 30 oncology clinics. The first year pilot will serve to inform the larger roll-out and the intervention may change during the first year based on pilot-clinic experience.

Interventions

OTHERClinician Communication Skills Training

Communication skills training

OTHERAdvance Care Planning (ACP) Decisions Videos Decisions Aids

ACP Decisions video decision aids

OTHERVideo Declarations (ViDec)

Recording of patient advance care planning videos

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Boston Medical Center
CollaboratorOTHER
Northwell Health
CollaboratorOTHER
Mayo Clinic
CollaboratorOTHER
Duke University
CollaboratorOTHER
National Institute on Aging (NIA)
CollaboratorNIH
Dana-Farber Cancer Institute
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

for clinics: Clinic eligibility criteria include: * More than one oncologist * Serve a patient population that is at least 30% aged 65 or older * Disease-based oncology clinic Subject Eligibility: (for the in-person surveys): \- Any patient affiliated with one of the study clinics who speaks English and is aged 65 or older with advanced cancer is eligible for participation. Advanced cancer is defined as metastatic disease for solid tumors and recurrent or refractory disease for hematological malignancies. There are no exclusions based on gender, race, or ethnicity.

Exclusion criteria

* Adults unable to consent * Individuals who are not yet adults (infants, children, teenagers) * Pregnant women * Prisoners

Design outcomes

Primary

MeasureTime frameDescription
Number of Participants With Advance Care Planning Documentation6 monthsAny advance directive (e.g., living will, POLST, etc.) and changes of resuscitation orders or any indication in the EHR of a goals-of-care or advance care planning conversation

Secondary

MeasureTime frameDescription
Rate of Palliative Care Consultation6 monthsUse of palliative care services (consults, outpatient visits) in the EHR
Rate of Hospice Use6 monthsUse of hospice documented in the EHR
Number of Participants With CODE Status Limitations6 monthsDocumented choices regarding CPR and mechanical ventilation in the EHR
Communication and Decisional Satisfaction6 months(In person survey) patient satisfaction with communication and decision making.The scale range is from 1- Strongly Disagree to 5 - Strongly Disagree. Higher values represent better outcomes. Subscales were combined questions were summed to compute a total score. The lowest possible score is a 9 and the highest possible score is 45. Lower scores indicate lower communication and decisional satisfaction.
Decisional Regret6 months(In person survey) patient regret regarding decision making. The response range is 1 - Strongly Disagree to 5 - Strongly agree. Higher numbers represent a worse outcome. Scale questions were summed to compute a total score. The lowest possible score is 2 and the highest possible score is 10. Lower scores indicate less decisional regret.
Confidence in Future Care6 months(in person survey) patient confidence that they will receive the right care at the right time by their health system. The scale ranged from 1 Not at all confident to 5 Very confident. Higher values represent a better outcome.

Countries

United States

Participant flow

Recruitment details

Recruitment was from April, 2020 - November, 2022. Locations: 36 cancer clinics

Pre-assignment details

This is a stepped-wedge, cluster randomized trial where clinics were randomized at various steps to move from a control period to the intervention periods. A total of 13,800 unique participants from 29 clinics were enrolled in the study. Participants could have contributed data multiple times during any step of the study.

Participants by arm

ArmCount
Intervention Arm
Patients with cancer being seen at the 30 oncology clinics will be exposed to clinicians who have had communication skills training (Vital Talk) and who are using video decision aids (ACP Decisions). Our main outcome is advance care planning documentation. Clinician Communication Skills Training: Communication skills training Advance Care Planning (ACP) Decisions Videos Decisions Aids: ACP Decisions video decision aids Video Declarations (ViDec): Recording of patient advance care planning videos
15,754
Usual Care Arm
Patients who were not exposed to any intervention
13,603
Total29,357

Baseline characteristics

CharacteristicIntervention ArmUsual Care ArmTotal
Age, Continuous74.4 Years
STANDARD_DEVIATION 6.6
74.6 Years
STANDARD_DEVIATION 6.7
74.5 Years
STANDARD_DEVIATION 6.6
Ethnicity (NIH/OMB)
Hispanic or Latino
454 Participants392 Participants846 Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
14750 Participants12,801 Participants27551 Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
550 Participants410 Participants960 Participants
Language
English
15096 Participants13067 Participants28163 Participants
Language
Other
554 Participants490 Participants1044 Participants
Language
Unknown
104 Participants46 Participants150 Participants
Race (NIH/OMB)
American Indian or Alaska Native
35 Participants27 Participants62 Participants
Race (NIH/OMB)
Asian
556 Participants479 Participants1035 Participants
Race (NIH/OMB)
Black or African American
1978 Participants1455 Participants3433 Participants
Race (NIH/OMB)
More than one race
1 Participants10 Participants11 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
7 Participants3 Participants10 Participants
Race (NIH/OMB)
Unknown or Not Reported
1347 Participants1188 Participants2535 Participants
Race (NIH/OMB)
White
11830 Participants10441 Participants22271 Participants
Sex: Female, Male
Female
7284 Participants6729 Participants14013 Participants
Sex: Female, Male
Male
8470 Participants6874 Participants15344 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
EG002
affected / at risk
EG003
affected / at risk
deaths
Total, all-cause mortality
0 / 5,7020 / 5,7020 / 5,7023,958 / 5,702
other
Total, other adverse events
0 / 5,7020 / 5,7020 / 5,7020 / 5,702
serious
Total, serious adverse events
0 / 5,7020 / 5,7020 / 5,7020 / 5,702

Outcome results

Primary

Number of Participants With Advance Care Planning Documentation

Any advance directive (e.g., living will, POLST, etc.) and changes of resuscitation orders or any indication in the EHR of a goals-of-care or advance care planning conversation

Time frame: 6 months

Population: The primary outcome measure was assessed at the participant level (all eligible patients) and not at the unit level.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention ArmNumber of Participants With Advance Care Planning DocumentationStep 31047 Participants
Intervention ArmNumber of Participants With Advance Care Planning DocumentationStep 41698 Participants
Intervention ArmNumber of Participants With Advance Care Planning DocumentationBaseline0 Participants
Intervention ArmNumber of Participants With Advance Care Planning DocumentationStep 1349 Participants
Intervention ArmNumber of Participants With Advance Care Planning DocumentationStep 2886 Participants
Usual Care ArmNumber of Participants With Advance Care Planning DocumentationStep 2511 Participants
Usual Care ArmNumber of Participants With Advance Care Planning DocumentationStep 1901 Participants
Usual Care ArmNumber of Participants With Advance Care Planning DocumentationStep 40 Participants
Usual Care ArmNumber of Participants With Advance Care Planning DocumentationStep 3259 Participants
Usual Care ArmNumber of Participants With Advance Care Planning DocumentationBaseline1163 Participants
p-value: <0.0595% CI: [2.8, 10.8]binomial regression with identity link
Secondary

Communication and Decisional Satisfaction

(In person survey) patient satisfaction with communication and decision making.The scale range is from 1- Strongly Disagree to 5 - Strongly Disagree. Higher values represent better outcomes. Subscales were combined questions were summed to compute a total score. The lowest possible score is a 9 and the highest possible score is 45. Lower scores indicate lower communication and decisional satisfaction.

Time frame: 6 months

Population: The secondary outcome measure was assessed at the participant level (all eligible patients) and not at the unit level.

ArmMeasureValue (MEAN)
Intervention ArmCommunication and Decisional Satisfaction44 units on a scale
Usual Care ArmCommunication and Decisional Satisfaction44 units on a scale
Secondary

Confidence in Future Care

(in person survey) patient confidence that they will receive the right care at the right time by their health system. The scale ranged from 1 Not at all confident to 5 Very confident. Higher values represent a better outcome.

Time frame: 6 months

Population: The secondary outcome measure was assessed at the participant level (all eligible patients) and not at the unit level.

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Intervention ArmConfidence in Future CareUnknown15 Participants
Intervention ArmConfidence in Future CareNone to little confidence4 Participants
Intervention ArmConfidence in Future CareSomewhat confident13 Participants
Intervention ArmConfidence in Future CareFairly confident27 Participants
Intervention ArmConfidence in Future CareVery Confident137 Participants
Usual Care ArmConfidence in Future CareVery Confident90 Participants
Usual Care ArmConfidence in Future CareUnknown5 Participants
Usual Care ArmConfidence in Future CareFairly confident15 Participants
Usual Care ArmConfidence in Future CareNone to little confidence4 Participants
Usual Care ArmConfidence in Future CareSomewhat confident8 Participants
Secondary

Decisional Regret

(In person survey) patient regret regarding decision making. The response range is 1 - Strongly Disagree to 5 - Strongly agree. Higher numbers represent a worse outcome. Scale questions were summed to compute a total score. The lowest possible score is 2 and the highest possible score is 10. Lower scores indicate less decisional regret.

Time frame: 6 months

Population: The secondary outcome measure was assessed at the participant level (all eligible patients) and not at the unit level.

ArmMeasureValue (MEAN)
Intervention ArmDecisional Regret2 units on a scale
Usual Care ArmDecisional Regret2 units on a scale
Secondary

Number of Participants With CODE Status Limitations

Documented choices regarding CPR and mechanical ventilation in the EHR

Time frame: 6 months

Population: The secondary outcome measure was assessed at the participant level (all eligible patients) and not at the unit level.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention ArmNumber of Participants With CODE Status LimitationsStep 158 Participants
Intervention ArmNumber of Participants With CODE Status LimitationsStep 3280 Participants
Intervention ArmNumber of Participants With CODE Status LimitationsStep 2155 Participants
Intervention ArmNumber of Participants With CODE Status LimitationsStep 4354 Participants
Intervention ArmNumber of Participants With CODE Status LimitationsBaseline0 Participants
Usual Care ArmNumber of Participants With CODE Status LimitationsStep 40 Participants
Usual Care ArmNumber of Participants With CODE Status LimitationsBaseline303 Participants
Usual Care ArmNumber of Participants With CODE Status LimitationsStep 1205 Participants
Usual Care ArmNumber of Participants With CODE Status LimitationsStep 2142 Participants
Usual Care ArmNumber of Participants With CODE Status LimitationsStep 374 Participants
p-value: <0.0595% CI: [-0.7, 0.6]binomial regression with identity link
Secondary

Rate of Hospice Use

Use of hospice documented in the EHR

Time frame: 6 months

Population: The secondary outcome measure was assessed at the participant level (all eligible patients) and not at the unit level.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention ArmRate of Hospice UseStep 150 Participants
Intervention ArmRate of Hospice UseStep 3350 Participants
Intervention ArmRate of Hospice UseStep 2260 Participants
Intervention ArmRate of Hospice UseStep 4468 Participants
Intervention ArmRate of Hospice UseBaseline0 Participants
Usual Care ArmRate of Hospice UseStep 40 Participants
Usual Care ArmRate of Hospice UseBaseline491 Participants
Usual Care ArmRate of Hospice UseStep 1348 Participants
Usual Care ArmRate of Hospice UseStep 2202 Participants
Usual Care ArmRate of Hospice UseStep 3108 Participants
p-value: <0.0595% CI: [-0.4, 1]binomial regression with identity link
Secondary

Rate of Palliative Care Consultation

Use of palliative care services (consults, outpatient visits) in the EHR

Time frame: 6 months

Population: The secondary outcome measure was assessed at the participant level (all eligible patients) and not at the unit level.

ArmMeasureGroupValue (COUNT_OF_PARTICIPANTS)
Intervention ArmRate of Palliative Care ConsultationStep 4648 Participants
Intervention ArmRate of Palliative Care ConsultationBaseline0 Participants
Intervention ArmRate of Palliative Care ConsultationStep 3443 Participants
Intervention ArmRate of Palliative Care ConsultationStep 1102 Participants
Intervention ArmRate of Palliative Care ConsultationStep 2324 Participants
Usual Care ArmRate of Palliative Care ConsultationStep 40 Participants
Usual Care ArmRate of Palliative Care ConsultationStep 2253 Participants
Usual Care ArmRate of Palliative Care ConsultationStep 3128 Participants
Usual Care ArmRate of Palliative Care ConsultationBaseline531 Participants
Usual Care ArmRate of Palliative Care ConsultationStep 1375 Participants
p-value: <0.0595% CI: [-0.5, 1.9]binomial regression with identity link

Source: ClinicalTrials.gov · Data processed: Feb 18, 2026